Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
Christian LabenzYvonne HuberEva KalligaMichael NagelChristian RuckesBeate K StraubPeter R GalleMarcus-Alexander WörnsQuentin M AnsteeDetlef SchuppanJörn Markus SchattenbergPublished in: Alimentary pharmacology & therapeutics (2018)
The prevalence of metabolic comorbidities in a German population with non-cirrhotic biopsy-proven NAFLD is high. While the examined scores exhibit an acceptable specificity, liver stiffness measurement appeared to be superior to blood-based non-invasive surrogate scores in ruling out advanced fibrosis.
Keyphrases